Rchr
J-GLOBAL ID:201801021319761913   Update date: Aug. 03, 2024

Ishizu Yoji

イシヅ ヨウジ | Ishizu Yoji
Affiliation and department:
Research field  (1): Gastroenterology
Research theme for competitive and other funds  (1):
  • 2021 - 2024 サルコペニア患者に対する腸内細菌叢への介入による効果的な運動療法の開発
Papers (359):
  • Fumitaka Mizuno, Norihiro Imai, Kazuyuki Mizuno, Shinya Yokoyama, Kenta Yamamoto, Takanori Ito, Yoji Ishizu, Takashi Honda, Hiroki Kawashima. Clinical Outcomes of Use of the Porous Glass Membrane Pumping Emulsification Device During Transarterial Chemoembolization for Hepatocellular Carcinoma. Anticancer research. 2024. 44. 7. 3185-3191
  • Masanao Nakamura, Takeshi Yamamura, Keiko Maeda, Tsunaki Sawada, Eri Ishikawa, Kentaro Murate, Kazuhiro Furukawa, Takashi Hirose, Kota Uetsuki, Tadashi Iida, et al. Long-term monitoring and clinical implications of small bowel capsule endoscopy in patients with Crohn's disease with small bowel lesions: A Retrospective Analysis. Digestion. 2024
  • Shinya Yokoyama, Takashi Honda, Yoji Ishizu, Norihiro Imai, Takanori Ito, Kenta Yamamoto, Kazuyuki Mizuno, Tetsuhito Kojima, Naoyoshi Kariya, Masanao Nakamura, et al. Risk factors for decreased bone mineral density in patients with metabolic dysfunction-associated steatotic liver disease: A cross-sectional study at a health examination center. Clinical nutrition (Edinburgh, Scotland). 2024. 43. 6. 1425-1432
  • Yosuke Inukai, Kenta Yamamoto, Takashi Honda, Shinya Yokoyama, Takanori Ito, Norihiro Imai, Yoji Ishizu, Masanao Nakamura, Masatoshi Ishigami, Hiroki Kawashima. Intestinal Microbiome Associated with Efficacy of Atezolizumab and Bevacizumab Therapy for Hepatocellular Carcinoma. Cancers. 2024. 16. 9
  • Takanori Ito, Kazuyuki Mizuno, Takafumi Yamamoto, Tsukasa Yasuda, Shinya Yokoyama, Kenta Yamamoto, Norihiro Imai, Yoji Ishizu, Takashi Honda, Masayo Hama, et al. Outcomes of immune checkpoint inhibitor-induced liver toxicity managed by hepatologists in a multidisciplinary toxicity team. Hepatology research : the official journal of the Japan Society of Hepatology. 2024
more...
MISC (80):
more...
Work history (1):
  • - 現在 Nagoya University Graduate School of Medicine Gastroenterology and hepatology
Association Membership(s) (4):
THE JAPANESE SOCIETY OF INTERNAL MEDICINE ,  日本門脈圧亢進症学会 ,  THE JAPAN SOCIETY OF HEPATOLOGY ,  JAPANESE SOCIETY OF GASTROENTEROLOGY
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page